We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 173

CMS issues final CY 2011 physician fee schedule rule
  • Reed Smith LLP
  • USA
  • November 16 2010

On November 29, 2010, CMS is publishing its final Medicare physician fee schedule (MPFS) rule for 2011.


In Pennsylvania products liability decisions, pharmaceutical manufacturers may lose a little, but gain a lot
  • Duane Morris LLP
  • USA
  • August 10 2010

In a trio of recent Pennsylvania Superior Court decisions involving the diet drug Redux, plaintiffs' lawyers may have gained a new cause of action against pharmaceutical manufacturers, but not before the reaffirmance of the learned intermediary defense and the rejection of a plaintiff's unique challenge to that defense.


A PMA device and a sales representative in the operating room - the breadth of Riegel preemption
  • Reed Smith LLP
  • USA
  • July 30 2008

A recent Virginia federal court decision demonstrates the powerful effect of the Riegel v. Medtronic precedent in product liability cases where PMA devices are subject to claims-sounding in negligence or breach of duty related to the design, manufacturing, and labeling of the device.




Mary M. Thomson
  • Gowling WLG


David W. Grauer
  • Squire Patton Boggs